29.12.2014 Views

terminology and guidelines for glaucoma ii - Kwaliteitskoepel

terminology and guidelines for glaucoma ii - Kwaliteitskoepel

terminology and guidelines for glaucoma ii - Kwaliteitskoepel

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

3.4 - COMPLIANCE IN GLAUCOMA<br />

Since <strong>glaucoma</strong> is a long-st<strong>and</strong>ing, progressive disease, which frequently requires topical medication <strong>and</strong> regular follow-up<br />

appointments, a patient’s continuous co-operation is essential <strong>for</strong> successful management.<br />

Compliance with <strong>glaucoma</strong> medications is considerably less than presumed by doctors <strong>and</strong> many patients fail to<br />

attend follow-up appointments 26-30 . Non-compliance is likely to have an important role in the progression to blindness<br />

from <strong>glaucoma</strong> 77 . Glaucoma patients are frequently old <strong>and</strong> may have diminished cognitive abilities, poor hearing<br />

<strong>and</strong> other ailments which, like arthritis, may reduce their ability to actually administer medication.<br />

Drug interactions <strong>and</strong> diminished drug tolerance must be taken into consideration. Consultation with other medical<br />

practitioners involved in the patient’s care may be necessary 23,75 .<br />

Compliance issues must be taken into account when the type of treatment is selected.<br />

Poor compliance is summarized as follows:<br />

1. Failure to instill eye drops (including ineffective technique of self-administration)<br />

2. Excessive use of eye drops (extra drops may cause systemic side effects)<br />

3. Self-administration of non-prescribed eye drops<br />

4. Improper timing of eye drops <strong>and</strong> eye drop administration <strong>for</strong> wrong reasons (a more frequent problem if nume<br />

rous drops are to be instilled <strong>and</strong> after changes in the patient’s topical medication regimen)<br />

How can compliance be improved<br />

1. Make the patient an active <strong>and</strong> in<strong>for</strong>med participant in his/her management. Glaucoma itself <strong>and</strong> the mechanism<br />

of the medication prescribed have to be explained. In addition, patients must be in<strong>for</strong>med about the symptoms of<br />

potential side effects. Written <strong>and</strong> audio-visual in<strong>for</strong>mation can be added to verbal education. If necessary, com<br />

munication with the patient’s family often helps to improve compliance.<br />

2. The number, concentration of drug <strong>and</strong> frequency should be kept to a minimum. Ocular irritation may be<br />

decreased by reducing the number of preserved eye drops 33-35 .<br />

3. Inconvenience caused by the medication has to be minimised, <strong>and</strong> the times of the eye drop instillation should be<br />

linked to l<strong>and</strong>marks of the patient’s daily routine.<br />

4. The patient should be taught how to instill eye drops correctly (correct technique of instillation, lid closure, punctal<br />

occlusion, use of instillation frames, time interval between administration of different drops etc). This knowledge<br />

is to be checked in practice. Ancillary medical staff can significantly help to accomplish this work.<br />

Ch. 3 - 27 EGS

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!